XTAI
3016
Market cap1.66bUSD
Oct 08, Last price
183.50TWD
1D
-5.90%
1Q
51.03%
Jan 2017
846.36%
IPO
1,547.22%
Name
Episil-Precision Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Episil-Precision Inc. (3016.TW) specializes in the full lifecycle of advanced epitaxial wafers, from their initial design and development through manufacturing and global distribution. These wafers utilize silicon (Si), silicon carbide (SiC), and gallium nitride (GaN) technologies. Their product portfolio includes silicon epitaxial wafers, SiC-on-SiC epitaxial wafers, and GaN-on-Si epitaxial wafers. These are crucial components for a diverse range of applications, including power discretes, integrated circuits for power management, image sensors, and various specialized epitaxial structures like graded, buried layer, and multi-layer designs. Beyond physical products, Episil-Precision also extends its expertise to providing buried layer epitaxial services. Established in 1998, the company maintains its corporate headquarters in Hsinchu City, Taiwan, and operates as a subsidiary under the umbrella of Episil Holding Inc.
Key people
J.S. Wen
General Manager · since 2025
Forest Chang
Deputy General Manager · since 2024
Shao-Hao Lyu
Deputy General Manager · since 2016
Peiyuan Chen
Head of Finance & Accounting · since 2021
Director · since 2021
J.H. Chiang
Director · since 2024
Wenying Liang
Director · since 2024
Eddy Peng
Director · since 2026
Chairman of the Board, Chief Strategy Officer · since 2023
Ze-Peng Chen
Independent Director · since 2015
Independent Director · since 2019
Wei-Min Shen
Independent Director · since 2016
D.L. Tseng
Independent Director · since 2025
Bing-Yue Tsui
Independent Director · since 2025
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||